08-Jul-2026 10:13:57
MARKSANSAcquisition and merger
MARKSANS PHARMA : GERMANY STEP-DOWN SUBSIDIARY ACQUIRES 100% ORDINARY SHARES OF ABCNOW GMBH
• Marksans Pharma Limited has entered into a definitive agreement to acquire 100% of the share capital of ABCnow GmbH, a Germany-based pharmaceutical company. • The acquisition marks a strategic step in expanding Marksans' presence across regulated European markets. • The target company has front-end sales, marketing, and distribution capabilities across the German healthcare market. • The acquisition is expected to be completed by July 31, 2026. • The consideration for the acquisition is €892,384 in cash. • ABCnow GmbH had a turnover of €227,233.69 as of December 31, 2025, and revenue of €510,215.60 in 2024.
Marksans Pharma Limited
Open attachment